Re: Limits of predictive models using microarray data for breast cancer clinical treatment outcome

J Natl Cancer Inst. 2005 Dec 21;97(24):1851-2; author reply 1852-3. doi: 10.1093/jnci/dji433.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / genetics
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / drug therapy*
  • DNA Primers
  • Female
  • Homeodomain Proteins / analysis*
  • Homeodomain Proteins / genetics
  • Humans
  • Microarray Analysis*
  • Patient Selection
  • Predictive Value of Tests
  • Receptors, Estrogen / analysis
  • Receptors, Interleukin / analysis*
  • Receptors, Interleukin / genetics
  • Receptors, Interleukin-17
  • Research Design
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Tamoxifen / therapeutic use*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • DNA Primers
  • HOXB13 protein, human
  • Homeodomain Proteins
  • IL17RB protein, human
  • Receptors, Estrogen
  • Receptors, Interleukin
  • Receptors, Interleukin-17
  • Tamoxifen